An observational study in Postoperative Neuromuscular Block and Postoperative Complications, sponsored by Hospital Universitario de Gran Canaria Doctor Negrín. Recruiting at 2 sites in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-08-24.
Sponsored by Hospital Universitario de Gran Canaria Doctor Negrín · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 69 studies in Postoperative Complications with a site in Spain — 13 open to participants now, 15 under way, 1 of them phase 3. Postoperative Complications · Spain.
Among the 69 studies in Postoperative Complications with a site in Spain, this one is the 23rd largest by planned enrollment of the 37 observational ones that give a count, is one of 3 that started in 2024, is one of 37 observational ones, reaches primary completion later than 2 of the 14 other live ones, and was the 59th registered.
1,343 studies on the registry are indexed under Postoperative Complications; 314 are open to participants now.
Browse Postoperative Complications studies →13 of the 69 studies in Postoperative Complications with a site in Spain are open now. Recruiting first, the newest first:
University of Seville · Sites in Spain
Ages 18–80
Zealand Pharma · Sites in Spain, United States, Austria and 11 more countries
Ages 18–90
Carlos Alfredo Fraile Olivero, MD, PhD. · Sites in Spain
Ages 18+
Francisco Andres de la Gala · Sites in Spain
Ages 18+
Hospital Universitari Vall d'Hebron Research Institute · Sites in Spain
Ages 18+
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 200 Postoperative Complications studies recruiting now, 126 (63%) set no upper age limit and 31 (16%) stop at 75 or younger; 24 take children under 18; 25 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
69 studies; the count open now beside each. This study's row is marked.
First in 1998; this study’s year is marked. 3 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 296 is above the median of 251 across 541 observational studies indexed under Postoperative Complications.
Median enrollment 178 across the 32 interventional studies, 400 across the 37 observational. Of the 41 that completed or were terminated, 3 (7%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 69 have an industry lead sponsor. The 10 most frequent:
Hospital Universitario de Gran Canaria Doctor Negrín is the lead sponsor of 11 studies on the registry; 7 are open to participants now.
Hospital Universitario de Gran Canaria Doctor Negrín has 2 studies filed under Postoperative Complications — fewer than ten, so there is no comparison to draw.
5 of the studies in Postoperative Complications with a site in Spain that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04973397Centre hospitalier de l'Université de Montréal (CHUM)Vascular Events In Patients Undergoing Same-day Noncardiac Surgery (VALIANCE) Study | 2026-12 |
| NCT04794582Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y CajalPrevention of Incisional Hernia After Renal Transplantation | 2026-12 |
| NCT07461779Francisco Andres de la GalaEffect of Oxygen Administration in the Non-dependent Lung on Postoperative Complications After Lung Surgery | 2026-12-30 |
| NCT06732193Carlos Alfredo Fraile Olivero, MD, PhD.Fissios© and Postoperative Complications (FPoC Trial) | 2026-12-31 |
| NCT07771049Hospital Universitario La FeOpioid-Free Anesthesia in Colorectal Surgery, 2025 (OFA-CRC-2025) | 2027-07-20 |
Add all 5 to your calendar (.ics) → With an account.
Among the 69 studies in Postoperative Complications with a site in Spain, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The use of neuromuscular blockers (NMB) is essential to optimize surgical conditions, ensure patient immobility during the intervention and prevent complications derived from involuntary movements. Intraoperative monitoring of neuromuscular relaxation allows the depth of neuromuscular blockade to be accurately evaluated, guaranteeing ideal conditions for the surgical team. Residual neuromuscular blockade (RNMB) is the persistence of muscle paralysis after the administration of NMB during a surgical intervention. The appearance of RNMB poses substantial challenges in the postoperative period, as it has negative repercussions for the safety and well-being of the patient.
The use of neuromuscular blockers (NMB) is essential to optimize surgical conditions, ensure patient immobility during the intervention and prevent complications derived from involuntary movements. Intraoperative monitoring of neuromuscular relaxation allows the depth of neuromuscular blockade to be accurately evaluated, guaranteeing ideal conditions for the surgical team. Residual neuromuscular blockade (RNMB) is the persistence of muscle paralysis after the administration of NMB during a surgical intervention. The appearance of RNMB poses substantial challenges in the postoperative period, as it has negative repercussions for the safety and well-being of the patient. In this prospective observational study, all patients who underwent general anesthesia with neuromuscular blockade were studied consecutively to evaluate the presence of residual neuromuscular blockade and its potential consequences during hospital admission.Considering that the percentage of residual curarization is 19% (PORCzero study), with a 95% confidence interval and a 3% error margin, 236 patients are needed to accurately estimate the prevalence of residual curarization in the study population. With an expected loss proportion of 20%, the chosen sample size is 296 patients.
Patients undergoing surgical intervention under general anesthesia that requires the use of neuromuscular block during the study time.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients submitted to General Anesthesia with Neuromuscular Block
Diagnostic Test: Train-of-four
Patients submitted to general anesthesia with neuromuscular block will be monitored at their arrival to the Post-Anesthesia Care Unit to assess the presence of residual neuromuscular block.
Residual Neuromuscular Block
Train-Of-Four ratio at arrival to the Post-Anesthetic Care Unit
Time frame: 5 minutes postoperatively
Residual Neuromuscular Block
Train-Of-Four ratio 3 minutes after the arrival to the Post-Anesthetic Care Unit
Time frame: 8 minutes postoperatively
Postoperative complications
Postoperative complications during hospital admission
Time frame: 30 days postoperatively
Plan to share: Undecided
No publications or documents are linked to this record.
Started May 2024 (actual). Primary completion is estimated for Oct 2025, 17 months after the start.
Of 276 non-industry observational studies under Postoperative Complications, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 39. This study's planned 17 months is below that.
Counting every sponsor, half of 281 studies reached it within 22 months; a quarter within 10 and three quarters within 39.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hospital Universitario de Gran Canaria Doctor Negrín